• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们应该多快调整降压药物的剂量?来自试验数据的系统评价模型血压反应。

How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data.

机构信息

Department of Primary Health Care, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK.

出版信息

Heart. 2011 Nov;97(21):1771-5. doi: 10.1136/hrt.2010.221473. Epub 2011 May 17.

DOI:10.1136/hrt.2010.221473
PMID:21586424
Abstract

CONTEXT

There are no evidence syntheses available to guide clinicians on when to titrate antihypertensive medication after initiation.

OBJECTIVE

To model the blood pressure (BP) response after initiating antihypertensive medication. Data sources electronic databases including Medline, Embase, Cochrane Register and reference lists up to December 2009.

STUDY SELECTION

Trials that initiated antihypertensive medication as single therapy in hypertensive patients who were either drug naive or had a placebo washout from previous drugs.

DATA EXTRACTION

Office BP measurements at a minimum of two weekly intervals for a minimum of 4 weeks. An asymptotic approach model of BP response was assumed and non-linear mixed effects modelling used to calculate model parameters.

RESULTS AND CONCLUSIONS

Eighteen trials that recruited 4168 patients met inclusion criteria. The time to reach 50% of the maximum estimated BP lowering effect was 1 week (systolic 0.91 weeks, 95% CI 0.74 to 1.10; diastolic 0.95, 0.75 to 1.15). Models incorporating drug class as a source of variability did not improve fit of the data. Incorporating the presence of a titration schedule improved model fit for both systolic and diastolic pressure. Titration increased both the predicted maximum effect and the time taken to reach 50% of the maximum (systolic 1.2 vs. 0.7 weeks; diastolic 1.4 vs. 0.7 weeks).

CONCLUSIONS

Estimates of the maximum efficacy of antihypertensive agents can be made early after starting therapy. This knowledge will guide clinicians in deciding when a newly started antihypertensive agent is likely to be effective or not at controlling BP.

摘要

背景

目前尚无证据综合可以指导临床医生在开始使用抗高血压药物后何时进行滴定。

目的

建立降压药物起始治疗后血压(BP)反应模型。

资料来源

电子数据库包括 Medline、Embase、Cochrane 注册库和参考文献,检索截至 2009 年 12 月。

研究选择

入选的试验为起始单药治疗的高血压患者,患者为初治或停用前药的安慰剂洗脱期。

数据提取

至少每周两次测量诊室 BP,至少 4 周。假设 BP 反应呈渐近模型,采用非线性混合效应模型计算模型参数。

结果与结论

共纳入 18 项试验,4168 例患者符合纳入标准。达到最大估计 BP 降低效果 50%的时间为 1 周(收缩压 0.91 周,95%CI 0.74 至 1.10;舒张压 0.95,0.75 至 1.15)。纳入药物类别作为变异源的模型并不能改善数据拟合。纳入滴定方案可改善收缩压和舒张压的模型拟合。滴定增加了最大预测效应和达到最大效应 50%的时间(收缩压 1.2 比 0.7 周;舒张压 1.4 比 0.7 周)。

结论

可在开始治疗后早期估计抗高血压药物的最大疗效。该知识将指导临床医生决定新开始的抗高血压药物何时可能有效或无效控制 BP。

相似文献

1
How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data.我们应该多快调整降压药物的剂量?来自试验数据的系统评价模型血压反应。
Heart. 2011 Nov;97(21):1771-5. doi: 10.1136/hrt.2010.221473. Epub 2011 May 17.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Blood pressure lowering efficacy of renin inhibitors for primary hypertension.肾素抑制剂对原发性高血压的降压疗效。
Cochrane Database Syst Rev. 2017 Apr 5;4(4):CD007066. doi: 10.1002/14651858.CD007066.pub3.
5
Eplerenone for hypertension.依普利酮用于治疗高血压。
Cochrane Database Syst Rev. 2017 Feb 28;2(2):CD008996. doi: 10.1002/14651858.CD008996.pub2.
6
Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.β1 选择性β受体阻滞剂对原发性高血压的降压疗效
Cochrane Database Syst Rev. 2016 Mar 10;3(3):CD007451. doi: 10.1002/14651858.CD007451.pub2.
7
Antihypertensive withdrawal for the prevention of cognitive decline.停用抗高血压药物以预防认知功能减退。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD011971. doi: 10.1002/14651858.CD011971.pub2.
8
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.用于预防激光小梁成形术后眼压暂时升高的围手术期药物。
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2.
9
Pharmacotherapy for hypertension in adults aged 18 to 59 years.18至59岁成年人高血压的药物治疗
Cochrane Database Syst Rev. 2017 Aug 16;8(8):CD008276. doi: 10.1002/14651858.CD008276.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
Development of the Double-Blind, Randomized Trials of Effects of Antihypertensive Medicines (DREAM) Database and Characteristics of the Included Trials: Protocol for an Umbrella Review and Meta-Analyses.降压药物疗效双盲随机试验(DREAM)数据库的开发及纳入试验的特征:一项伞状综述和荟萃分析方案
JMIR Res Protoc. 2025 Aug 21;14:e65205. doi: 10.2196/65205.
2
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1.在基层医疗卫生机构整合高血压与心血管-肾脏-代谢护理的候选干预措施:HEARTS 2.0 第一阶段
Glob Heart. 2025 May 27;20(1):45. doi: 10.5334/gh.1428. eCollection 2025.
3
A simulation-based framework for modeling and prediction of personalized blood pressure trajectories in hypertensive patients after antihypertensive treatment.
一种基于模拟的框架,用于对高血压患者降压治疗后的个性化血压轨迹进行建模和预测。
PLoS One. 2025 Apr 10;20(4):e0318549. doi: 10.1371/journal.pone.0318549. eCollection 2025.
4
N-of-1 tests in general practice: pharmacological considerations.全科医疗中的单病例试验:药理学考量
Br J Gen Pract. 2025 Feb 27;75(752):132-135. doi: 10.3399/bjgp25X740985. Print 2025 Mar.
5
Home blood pressure during night-time sleep - a feasible treatment target for patients with hypertension: a proof-of-concept randomised controlled trial.夜间睡眠期间的家庭血压——高血压患者的一个可行治疗靶点:一项概念验证随机对照试验
J Pharm Policy Pract. 2025 Feb 14;18(1):2463435. doi: 10.1080/20523211.2025.2463435. eCollection 2025.
6
Evening dosing versus morning dosing of antihypertensive medications for nocturnal hypertension: a systematic review and meta-analysis of 107 randomized controlled trials.降压药物晚间给药与清晨给药治疗夜间高血压的疗效比较:107 项随机对照试验的系统评价和荟萃分析。
J Hypertens. 2024 Oct 1;42(10):1653-1664. doi: 10.1097/HJH.0000000000003783. Epub 2024 Jun 14.
7
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension.治疗高血压的新型低剂量三联单片复方制剂的理由。
Glob Heart. 2024 Feb 14;19(1):18. doi: 10.5334/gh.1283. eCollection 2024.
8
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial.四种降压药物血压反应的异质性:一项随机临床试验。
JAMA. 2023 Apr 11;329(14):1160-1169. doi: 10.1001/jama.2023.3322.
9
A Case Report of Lifesaving Intravenous Bolus Epinephrine Administration in a Case of Severe Refractory Anaphylactic Shock.一例严重难治性过敏性休克患者静脉推注肾上腺素挽救生命的病例报告
Cureus. 2022 Aug 22;14(8):e28249. doi: 10.7759/cureus.28249. eCollection 2022 Aug.
10
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.台湾心脏病学会与台湾高血压学会2022年高血压管理指南
Acta Cardiol Sin. 2022 May;38(3):225-325. doi: 10.6515/ACS.202205_38(3).20220321A.